Arnold & Porter

Arnold & Porter is pleased to announce that Daphne O’Connor, co-chair of the firm’s Product Liability Litigation practice group,

A new report commissioned by Arnold & Porter, based on a survey of 100 senior executives and department heads from biopharmaceutical,

Arnold & Porter announced today that Bill Efron, former Director of the Federal Trade Commission’s (FTC) Northeast Regional Office, has joined the firm’s Antitrust practice as a partner, resident in New York.

Arnold & Porter announced today that Todd Boudreau has joined the firm’s Corporate & Finance practice with a focus on Private Equity, Institutional Investments, and Fund Formation as a partner, resident in Boston.

Arnold & Porter announced today that Brian Dunphy has joined the firm’s Complex Litigation practice as a partner, resident in Boston.

Arnold & Porter announced today that Matthew Cudrin has joined the firm’s Real Estate practice as a partner, resident in New York.

Arnold & Porter announced today that Matthew Micheli has joined the firm’s Bankruptcy and Restructuring practice as a partner, resident in Chicago.

Arnold & Porter announced today that Eva Temkin, former FDA Counsel and Acting Director for Policy at the U.S. Food and Drug Administration’s Office of Therapeutic Biologics and Biosimilars,

NEWARK, N.J., and NEW YORK, March 25, 2024 — Arnold & Porter is pleased to announce the continuing growth of its Newark office with the arrival of Lee Cortes, former Executive Assistant United States Attorney for the District of New Jersey.

NEWARK, N.J., and BOSTON, March 25, 2024 — Arnold & Porter is pleased to announce the continuing growth of its Environmental practice with the arrival of Jeffrey Talbert and Ben Piper.

Arnold & Porter announced today that a seven-lawyer team, including six partners and one counsel, has joined the firm in its Chicago, Denver, and New York offices.